TL
Insider
Tactic Pharma LLC
Chief Executive OfficerTactic Pharma LLC (Chief Executive Officer) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $35.0M of MNPR (550,229 sh × $63.61, as filed), executed Sep 24 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 24 2025
Filed Sep 26 2025
Median ADV $24.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $36.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MNPRRecent filings
MNPRSALE
Monopar Therapeutics Inc.
View filing →
$35.0M550,229 sh × $63.61
Exec Sep 24 2025
Filed Sep 26 2025 · 5:30 PM ET MNPRSALE Monopar Therapeutics Inc. View filing → $1.2M
33,334 sh × $35.00
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET